/Lists

Biotech Growth Investors & VC Firms

708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

OrbiMed
New YorkSeed–Late Stage$1M – $75M
92 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
30 people
In-Q-Tel
TysonsSeed–Growth$100K – $2.5M
23 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
96 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Aju IB Investment
SeoulGrowth
39 people
Saints Capital
San FranciscoGrowth–Late Stage
18 people
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
86 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
Octopus Ventures
LondonPre-Seed–Growth$130K – $1.3M
35 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
35 people
Arsenal
New YorkGrowth
111 people
JAFCO Group
TokyoPre-Seed–Growth
89 people
Sofinnova Partners
ParisSeed–Late Stage$540K – $27M
79 people
Andera Partners
ParisSeed–Growth
44 people
BDC Venture Capital
MontrealPre-Seed–Growth$365K – $25.6M
109 people
Deerfield Management Company
New YorkGrowth–Late Stage
96 people
Atinum Investment Co. Ltd.
SeoulSeries B–Growth$100K – $2M
44 people
CDP Venture Capital
RomaPre-Seed–Growth
44 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
60 people
Frazier Healthcare Partners
SeattleGrowth$50M – $400M
91 people
Foresite Capital
West HollywoodSeed–Late Stage
43 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.